Home LiteratureArticle Details
PMID: 7887441 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon-gamma and tumor necrosis factor-alpha.

The American journal of pathology ·Vol. 146 ·No. 3 ·1995-03-00 ·Pages 589-98

Delvenne P, al-Saleh W, Gilles C, Thiry A, Boniver J

Abstract

The growth response of normal and human papillomavirus (HPV)-transformed cervical keratinocytes to interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha was investigated in monolayer and organotypic raft cultures. The proliferation rates of monolayer cultures were assessed by [3H]TdR incorporation and fluorimetric DNA titration. The growth of keratinocytes in organotypic cultures was estimated by their ability to stratify on collagen rafts and by immunohistochemistry for Ki67 antigen expression. IFN-gamma reduced the DNA synthesis of normal and HPV-transformed keratinocytes in monolayer cultures and exerted a marked growth inhibitory effect in organotypic raft cultures. In control raft cultures, normal keratinocytes produced an epithelial sheet of approximately 10 cells in thickness that closely resembled normal cervical epithelium and was characterized by sparse Ki67 antigen-positive cells whereas HPV-transformed keratinocytes produced up to 15 poorly differentiated epithelial layers that were reminiscent of high grade cervical lesions seen in vivo and exhibited a full thickness Ki67 antigen expression. When normal and HPV-transformed keratinocytes were maintained in the presence of IFN-gamma, the epithelial sheet was reduced to a few cells in thickness and the density of Ki67 antigen-positive cells was decreased. A more pronounced growth inhibitory effect in monolayer and organotypic cultures was observed when IFN-gamma was associated with tumor necrosis factor-alpha Tumor necrosis factor-alpha alone reduced the DNA synthesis of normal keratinocytes but was significantly less effective than IFN-gamma to inhibit the growth of HPV-transformed keratinocytes. These results suggest that similar responses in vivo to regulatory molecules may play a role in the development of HPV-related lesions.

MeSH Terms
Cell Division/drug effects Cell Line, Transformed/drug effects Cells, Cultured Cytological Techniques Humans Interferon-gamma/pharmacology Keratinocytes/cytology,drug effects Papillomaviridae/physiology Reference Values Tumor Necrosis Factor-alpha/pharmacology
Chemicals
Tumor Necrosis Factor-alpha Interferon-gamma
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Delvenne P
Department of Pathology, University Hospital of Liège, Belgium.
al-Saleh W
Gilles C
Thiry A
Boniver J
References (52)
52 references, click to expand
  1. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.
    Science. 1985 Nov 22;230(4728):943-5 PMID: 3933111
  2. Immortalization of human cervical keratinocytes by human papillomavirus type 33.
    Int J Cancer. 1993 Mar 12;53(5):872-9 PMID: 8383632
  3. Immunological abnormalities in patients with cervical carcinoma.
    Gynecol Oncol. 1986 Sep;25(1):61-4 PMID: 3732919
  4. Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts.
    Cancer. 1986 Sep 15;58(6):1246-51 PMID: 3017534
  5. Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.
    J Clin Pathol. 1986 Sep;39(9):977-80 PMID: 3020096
  6. Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor.
    J Exp Med. 1986 Oct 1;164(4):1350-5 PMID: 3020152
  7. Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines.
    Am J Pathol. 1993 May;142(5):1544-55 PMID: 8098584
  8. Keratinocytes: key immunocytes of the integument.
    Am J Pathol. 1993 Aug;143(2):325-31 PMID: 8342589
  9. Characterization and functional analysis of the expression of intercellular adhesion molecule-1 in human papillomavirus-related disease of cervical keratinocytes.
    Am J Pathol. 1993 Aug;143(2):355-67 PMID: 8102029
  10. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
    J Exp Med. 1993 Sep 1;178(3):1041-8 PMID: 8102388
  11. Interleukin-12 and its role in the generation of TH1 cells.
    Immunol Today. 1993 Jul;14(7):335-8 PMID: 8103338
  12. Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology.
    Proc Soc Exp Biol Med. 1970 Nov;135(2):543-5 PMID: 5529598
  13. A simple, rapid, and sensitive DNA assay procedure.
    Anal Biochem. 1980 Mar 1;102(2):344-52 PMID: 6158890
  14. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.
    Proc Natl Acad Sci U S A. 1983 Sep;80(17):5397-401 PMID: 6193516
  15. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.
    J Immunol. 1984 Oct;133(4):1710-5 PMID: 6206131
  16. Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes.
    Lab Invest. 1984 Dec;51(6):697-701 PMID: 6209471
  17. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix.
    Virology. 1985 Sep;145(2):313-8 PMID: 2992153
  18. Increased tumorigenicity of human keratinocytes harboring human papillomavirus type 16 is associated with resistance to endogenous tumor necrosis factor-alpha-mediated growth limitation.
    Int J Cancer. 1994 Feb 15;56(4):593-8 PMID: 8112896
  19. Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines.
    Cancer Res. 1987 Jan 1;47(1):145-9 PMID: 3791201
  20. Subpopulations of Langerhans' cells in cervical neoplasia.
    Br J Obstet Gynaecol. 1987 Jan;94(1):10-5 PMID: 3028467
  21. Lymphocyte phenotypes in cervical intraepithelial neoplasia and human papillomavirus infection.
    Br J Obstet Gynaecol. 1987 Jan;94(1):16-21 PMID: 3028468
  22. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
    Cancer Res. 1987 May 15;47(10):2563-70 PMID: 3105865
  23. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.
    Cancer Res. 1987 Jun 1;47(11):2809-13 PMID: 3105867
  24. A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3293-7 PMID: 3033642
  25. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells.
    EMBO J. 1987 Jun;6(6):1741-6 PMID: 3038534
  26. Oncogenic association of specific human papillomavirus types with cervical neoplasia.
    J Natl Cancer Inst. 1987 Oct;79(4):671-7 PMID: 2821311
  27. Interferon treatment of human genital papillomavirus infection: importance of viral type.
    Int J Cancer. 1987 Nov 15;40(5):610-4 PMID: 3679588
  28. Characterization of primary human keratinocytes transformed by human papillomavirus type 18.
    J Virol. 1988 Jun;62(6):1917-24 PMID: 2452896
  29. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA.
    Oncogene. 1987;1(3):251-6 PMID: 2838778
  30. Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells.
    Proc Natl Acad Sci U S A. 1988 Jul;85(14):5102-6 PMID: 2899323
  31. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro.
    Proc Natl Acad Sci U S A. 1988 Oct;85(19):7169-73 PMID: 2459699
  32. Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras.
    Oncogene. 1989 Apr;4(4):395-9 PMID: 2541388
  33. Ki67 immunostaining in primary breast cancer: pathological and clinical associations.
    Br J Cancer. 1989 Jun;59(6):943-7 PMID: 2472168
  34. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.
    J Virol. 1989 Oct;63(10):4417-21 PMID: 2476573
  35. In situ hybridization analysis of human papillomavirus DNA segregation patterns in lesions of the female genital tract.
    Gynecol Oncol. 1990 Feb;36(2):256-62 PMID: 2153624
  36. Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors.
    J Clin Invest. 1990 Feb;85(2):605-8 PMID: 2105343
  37. Immunohistology of genital warts in different stages of regression after therapy with interferon gamma.
    Dermatologica. 1989;179(4):191-5 PMID: 2533570
  38. Interferon gamma treatment for cervical intraepithelial neoplasia.
    Gynecol Oncol. 1990 Apr;37(1):96-102 PMID: 2108910
  39. Selective suppression of human papilloma virus type 18 mRNA level in HeLa cells by interferon.
    Biochem Biophys Res Commun. 1990 Jul 31;170(2):793-9 PMID: 1696477
  40. Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture.
    Am J Pathol. 1991 Mar;138(3):673-85 PMID: 1848042
  41. Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells.
    Cancer Res. 1992 Jan 15;52(2):456-63 PMID: 1345813
  42. Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture.
    Am J Pathol. 1992 Jan;140(1):167-77 PMID: 1370596
  43. Analysis by in situ hybridization of cells expressing mRNA for tumor-necrosis factor in the developing thymus of mice.
    Dev Immunol. 1992;2(2):103-9 PMID: 1643416
  44. Differential effect of tumor necrosis factor on proliferation of primary human keratinocytes and cell lines containing human papillomavirus types 16 and 18.
    Mol Carcinog. 1992;6(1):5-9 PMID: 1323969
  45. Downmodulation of c-myc expression by interferon gamma and tumour necrosis factor alpha precedes growth arrest in human melanoma cells.
    Eur J Cancer. 1992;28A(10):1622-7 PMID: 1389476
  46. Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-alpha.
    J Immunol. 1992 Oct 15;149(8):2702-8 PMID: 1328383
  47. Interferon-gamma induces cell surface expression for both types of tumor necrosis factor receptors.
    FEBS Lett. 1992 Nov 2;312(1):87-90 PMID: 1330686
  48. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues.
    J Pathol. 1992 Sep;168(1):85-6 PMID: 1453271
  49. Ki67--structure, function, and new antibodies.
    J Pathol. 1992 Oct;168(2):161-2 PMID: 1460534
  50. Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors.
    Cancer Res. 1993 Feb 1;53(3):636-40 PMID: 8425199
  51. Shope papilloma cell and leukocyte proliferation in regressing and progressing lesions.
    Am J Pathol. 1993 Feb;142(2):489-96 PMID: 8434644
  52. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons.
    Cancer Res. 1986 Aug;46(8):3990-3 PMID: 2425938
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1995-03-00
Pages
589-98
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1869174
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com